BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 4, 2010
View Archived Issues
ENB-0040 shows promise to treat hypophosphatasia in children
Read More
Serodus identifies new serotonin 5-HT4 receptor antagonists
Read More
AMG-386 is active in renal cell carcinoma and ovarian cancer
Read More
Panobinostat has antitumor activity in phase II trial in SCLC
Read More
Adjuvanted VZV subunit vaccine gE/AS01B is more immunogenic than Varilrix
Read More
CMX-001 effective in immunocompromised adenovirus-infected patients
Read More
Pradaxa arrives in U.S. pharmacies
Read More
Primary endpoint met in phase III HPN-100 trial in urea cycle disorders
Read More
Incyte begins global phase III INCB-18424 trial in polycythemia vera
Read More
Shire presents new prodrugs of opioids for the treatment of pain
Read More
Phase III data reported on linaclotide in IBS with constipation
Read More
New ligands of glucocorticoid receptors disclosed by AstraZeneca
Read More
RegeneRx Biopharma reports preclinical data on RGN-259 for dry eye syndrome
Read More
New metabotropic glutamate mGlu2 receptor agonists claimed
Read More
CeNeRx BioPharma presents safety data on new CX-157 formulation
Read More
Medicago's H5N1 avian flu vaccine approved to enter phase II trial
Read More
New beta-secretase 1 inhibitors patented
Read More
FDA approves Teflaro for CABP and ABSSSI in adults
Read More
Soligenix presents preliminary phase Ib safety data on RiVax
Read More
BC-819 shows good safety profile in phase I/IIa trial in pancreatic cancer
Read More
MabThera approved in E.U. as maintenance treatment of follicular lymphoma
Read More
Viralytics submits IND for phase II trial of Cavatak in melanoma
Read More
Phase II CD-NP trial in acute decompensated heart failure meets endpoint
Read More
Gynecologic Oncology Group to begin phase II elesclomol trial in ovarian cancer
Read More
FDA extends review of BMS' BLA for ipilimumab in advanced melanoma
Read More